237 related articles for article (PubMed ID: 23489758)
1. Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?
Seibold P; Hall P; Schoof N; Nevanlinna H; Heikkinen T; Benner A; Liu J; Schmezer P; Popanda O; Flesch-Janys D; Chang-Claude J
Breast; 2013 Oct; 22(5):817-23. PubMed ID: 23489758
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
[TBL] [Abstract][Full Text] [Related]
3. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer.
Bewick MA; Conlon MS; Lafrenie RM
Breast Cancer Res Treat; 2008 Sep; 111(1):93-101. PubMed ID: 17922231
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.
Ambrosone CB; Ahn J; Singh KK; Rezaishiraz H; Furberg H; Sweeney C; Coles B; Trovato A
Cancer Res; 2005 Feb; 65(3):1105-11. PubMed ID: 15705913
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer.
Ahn J; Ambrosone CB; Kanetsky PA; Tian C; Lehman TA; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Clin Cancer Res; 2006 Dec; 12(23):7063-70. PubMed ID: 17145829
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
Seibold P; Hein R; Schmezer P; Hall P; Liu J; Dahmen N; Flesch-Janys D; Popanda O; Chang-Claude J
Int J Cancer; 2011 Sep; 129(6):1467-76. PubMed ID: 21792883
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer.
Hong CC; Ambrosone CB; Ahn J; Choi JY; McCullough ML; Stevens VL; Rodriguez C; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1784-94. PubMed ID: 17726138
[TBL] [Abstract][Full Text] [Related]
10. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving Radiotherapy.
Córdoba EE; Abba MC; Lacunza E; Fernánde E; Güerci AM
Cancer Res Treat; 2016 Jul; 48(3):948-54. PubMed ID: 26790968
[TBL] [Abstract][Full Text] [Related]
12. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
13. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of TP53 and EPHX1 in Leber's hereditary optic neuropathy and their relationship to age at onset.
Ishikawa K; Funayama T; Ohde H; Inagaki Y; Mashima Y
Jpn J Ophthalmol; 2005; 49(2):121-6. PubMed ID: 15838728
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
[TBL] [Abstract][Full Text] [Related]
16. Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.
Hubackova M; Vaclavikova R; Ehrlichova M; Mrhalova M; Kodet R; Kubackova K; Vrána D; Gut I; Soucek P
Int J Cancer; 2012 Jan; 130(2):338-48. PubMed ID: 21351093
[TBL] [Abstract][Full Text] [Related]
17. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Fagerholm R; Hofstetter B; Tommiska J; Aaltonen K; Vrtel R; Syrjäkoski K; Kallioniemi A; Kilpivaara O; Mannermaa A; Kosma VM; Uusitupa M; Eskelinen M; Kataja V; Aittomäki K; von Smitten K; Heikkilä P; Lukas J; Holli K; Bartkova J; Blomqvist C; Bartek J; Nevanlinna H
Nat Genet; 2008 Jul; 40(7):844-53. PubMed ID: 18511948
[TBL] [Abstract][Full Text] [Related]
19. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
[TBL] [Abstract][Full Text] [Related]
20. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]